Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
FDA advisory panel is convening this week to decide whether to recommend approval of Egrifta, a belly fat-busting drug.
An advisory panel on vaccines at the Centers for Disease Control and Prevention (CDC) in Atlanta has decided not to recommend the human...
A Food and Drug Administration (FDA) advisory panel has recommended that the FDA grant approval to Selzentry (maraviroc) for HIV-positive...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.